TSHA · CIK 0001806310 · operating
Taysha Gene Therapies, Inc. (TSHA) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.2 billion, Taysha Gene Therapies, Inc. is a small-cap company. The stock currently trades at $4.53, up 0.00% today, with a 52-week range of $1.05–$6.02.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.36 | $-0.36 | +62.5% | |
| 2023 | $-0.96 | $-0.96 | +74.6% | |
| 2022 | $-3.78 | $-3.78 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |